{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:58:24Z","timestamp":1756076304774},"reference-count":27,"publisher":"Baishideng Publishing Group Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4254\/wjh.v2.i9.358","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T09:24:19Z","timestamp":1285838659000},"page":"358","source":"Crossref","is-referenced-by-count":5,"title":["Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C"],"prefix":"10.4254","volume":"2","author":[{"given":"Kazuaki","family":"Nishio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Boonen A, Stockbr&uuml;gger RW, van der Linden S. Pericarditis after therapy with interferon-alpha for chronic hepatitis C. Clin Rheumatol 1999;18:177-179.","DOI":"10.1007\/s100670050081"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Wisniewski B, Denis J, Fischer D, Labayle D. [Pericarditis secondary to interferon alpha in chronic hepatitis C]. Gastroenterol Clin Biol 2004;28:315-316.","DOI":"10.1016\/S0399-8320(04)94929-9"},{"key":"ref3","unstructured":"Gressens B, Gohy P. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C. Acta Gastroenterol Belg 2004;67:301-302."},{"key":"ref4","unstructured":"Benjamini O, Kimhi O, Lishner M. Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b. Isr Med Assoc J 2007;9:486-487."},{"key":"ref5","unstructured":"Hamdani I, Kochlef A, Belhadj N, Kharrat J, Ghorbel A. [Acute pericardite which has occurred during the treatment of chronic hepatitis C by the interferon alpha2A]. Tunis Med 2008;86:404-405."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Marzo ME, Tintor&eacute; M, Fabregues O, Montalb&aacute;n X, Codina A. Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha. J Neurol Neurosurg Psychiatry 1998;65:604.","DOI":"10.1136\/jnnp.65.4.604"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol 2008;14:318-321.","DOI":"10.3748\/wjg.14.318"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Hirotani M, Nakano H, Ura S, Yoshida K, Niino M, Yabe I, Sasaki H. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Intern Med 2009;48:373-375.","DOI":"10.2169\/internalmedicine.48.1616"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kato-Motozaki Y, Komai K, Takahashi K, Ishida C, Ueda M, Kusunoki S, Yamada M. Polyethylene glycol interferon alpha-2b-induced immune-mediated polyradiculoneuropathy. Intern Med 2009;48:569-572.","DOI":"10.2169\/internalmedicine.48.1794"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.","DOI":"10.1056\/NEJM200107053450107"},{"key":"ref11","unstructured":"Mansat-Krzyzanowska E, Dr&eacute;no B, Chiffoleau A, Litoux P. [Cardiovascular manifestations associated with interferon alfa-2A]. Ann Med Interne (Paris) 1991;142:576-581."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Teragawa H, Hondo T, Amano H, Hino F, Ohbayashi M. Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C. Jpn Heart J 1996;37:905-915.","DOI":"10.1536\/ihj.37.905"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res 2005;96:144-147.","DOI":"10.1161\/01.RES.0000156077.54903.67"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.","DOI":"10.1016\/S0049-0172(97)80005-4"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996;25:283-291.","DOI":"10.1016\/S0168-8278(96)80113-9"},{"key":"ref16","unstructured":"Chung YH, Shong YK. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis. Am J Gastroenterol 1993;88:244-247."},{"key":"ref17","unstructured":"T&eacute;llez-Zenteno JF, Negrete-Pulido O, Nu\u00f1ez M, Esta\u00f1ol-Vidal B, Garc&iacute;a-Ramos G. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature]. Rev Neurol 2002;35:644-646."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Emir S, Kutluk T, Chan KW, Yal&ccedil;in B, Varli K, B&uuml;y&uuml;kpamuk&ccedil;u M. Peripheral neuropathy during alpha-interferon therapy in a child with Hodgkin&rsquo;s disease. Pediatr Hematol Oncol 1999;16:557-560.","DOI":"10.1080\/088800199276868"},{"key":"ref19","unstructured":"Lapi\u0144ski TW, Nowacka B, Michalewicz M. [The peripheral polyneuropathy in patients with chronic HCV infection treated peginterferon alfa with ribavirin]. Pol Merkur Lekarski 2005;18:431-432."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Marey-L&oacute;pez J, Sousa CP. Trigeminal sensory neuropathy related to interferon-alpha treatment. Muscle Nerve 2006;33:581-582.","DOI":"10.1002\/mus.20487"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Irioka T, Yamada M, Yamawaki M, Saito Y, Mizusawa H, Yamada M, Miura H. Acute autonomic and sensory neuropathy after interferon alpha-2b therapy for chronic hepatitis C. J Neurol Neurosurg Psychiatry 2001;70:408-410.","DOI":"10.1136\/jnnp.70.3.408"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Hoare M, Woodall T, Alexander GJ. Bell&rsquo;s palsy associated with IFN-alpha and ribavirin therapy for hepatitis C virus infection. J Interferon Cytokine Res 2005;25:174-176.","DOI":"10.1089\/jir.2005.25.174"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Meriggioli MN, Rowin J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve 2000;23:433-435.","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<433::AID-MUS17>3.0.CO;2-O"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Lin W, Harding HP, Ron D, Popko B. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 2005;169:603-612.","DOI":"10.1083\/jcb.200502086"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Lin W, Kemper A, Dupree JL, Harding HP, Ron D, Popko B. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 2006;129:1306-1318.","DOI":"10.1093\/brain\/awl044"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Hughes RA. Management of chronic inflammatory demyelinating polyradiculoneuropathy. Drugs 2003;63:275-287.","DOI":"10.2165\/00003495-200363030-00003"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"van Doorn PA, Ruts L. Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 2004;17:607-613.","DOI":"10.1097\/00019052-200410000-00011"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T04:41:56Z","timestamp":1559709716000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v2\/i9\/358.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v2.i9.358","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}